Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04958304 · ClinicalTrials.gov registry record
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
A clinical trial, sponsored by ModernaTX.
- Terminated
- Registry status
- 20
- Enrollment target
NCT04958304: Clinical Trial study, sponsored by ModernaTX.
NCT04958304 is a clinical trial that was terminated before completion, run by ModernaTX. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04958304 was terminated before completion, sponsored by ModernaTX.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The main goal of this study is to evaluate the outcomes of pregnancy in females exposed to the Moderna COVID-19 vaccine (mRNA-1273) during pregnancy.
Primary Outcome
Major malformations are those that have significant medical, social or cosmetic consequences, and typically require surgical intervention or are life-threatening (for example, cleft lip, spina bifida).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2023-09-22 |
Why NCT04958304 stopped before completion
NCT04958304 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04958304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04958304 about?
NCT04958304 is a clinical study titled "Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study". The main goal of this study is to evaluate the outcomes of pregnancy in females exposed to the Moderna COVID-19 vaccine (mRNA-1273) during pregnancy.
What is the current status of trial NCT04958304?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2021-09-01. Estimated completion is 2023-09-22.
Who is sponsoring clinical trial NCT04958304?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI